84 related articles for article (PubMed ID: 22180476)
1. ALDH, CA I, and CD2AP: novel, diagnostically useful immunohistochemical markers to identify erythroid precursors in bone marrow biopsy specimens.
Rollins-Raval MA; Fuhrer K; Marafioti T; Roth CG
Am J Clin Pathol; 2012 Jan; 137(1):30-8. PubMed ID: 22180476
[TBL] [Abstract][Full Text] [Related]
2. CD71 is selectively and ubiquitously expressed at high levels in erythroid precursors of all maturation stages: a comparative immunochemical study with glycophorin A and hemoglobin A.
Dong HY; Wilkes S; Yang H
Am J Surg Pathol; 2011 May; 35(5):723-32. PubMed ID: 21415701
[TBL] [Abstract][Full Text] [Related]
3. CD71 (transferrin receptor): an effective marker for erythroid precursors in bone marrow biopsy specimens.
Marsee DK; Pinkus GS; Yu H
Am J Clin Pathol; 2010 Sep; 134(3):429-35. PubMed ID: 20716799
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin is a specific marker for erythroid differentiation and has utility, in combination with CD117 and CD34, for enumerating myeloblasts in hematopoietic neoplasms.
Ohgami RS; Chisholm KM; Ma L; Arber DA
Am J Clin Pathol; 2014 May; 141(5):656-64. PubMed ID: 24713736
[TBL] [Abstract][Full Text] [Related]
5. The adhesion molecule E-cadherin and a surface antigen recognized by the antibody 9C4 are selectively expressed on erythroid cells of defined maturational stages.
Bühring HJ; Müller T; Herbst R; Cole S; Rappold I; Schuller W; Zhu X; Fritzsch U; Faul C; Armeanu S; Ullrich A; Klein G; Schmidt H
Leukemia; 1996 Jan; 10(1):106-16. PubMed ID: 8558914
[TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case.
Heiss S; Erdel M; Gunsilius E; Nachbaur D; Tzankov A
Hum Pathol; 2005 Oct; 36(10):1148-51. PubMed ID: 16226118
[TBL] [Abstract][Full Text] [Related]
7. NRP-1/CD304 expression in acute leukemia: a potential marker for minimal residual disease detection in precursor B-cell acute lymphoblastic leukemia.
Meyerson HJ; Blidaru G; Edinger A; Osei E; Schweitzer K; Fu P; Ho L
Am J Clin Pathol; 2012 Jan; 137(1):39-50. PubMed ID: 22180477
[TBL] [Abstract][Full Text] [Related]
8. [Role of CD2-associated protein and nephrin expression in multilocular cystic renal cell carcinoma].
Gong K; Zhao ZX; Lü TJ; Jin J
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):543-7. PubMed ID: 19567077
[TBL] [Abstract][Full Text] [Related]
9. Expression of the CD2AP adaptor molecule in normal, reactive and neoplastic human tissue.
Rizvi H; Paterson JC; Tedoldi S; Ramsay A; Calaminici M; Natkunam Y; Lonardi S; Tan SY; Campbell L; Hansmann ML; Jones D; Dikic I; Shaw AS; Pileri SA; Stein H; Mason DY; Facchetti F; Marafioti T
Pathologica; 2012 Apr; 104(2):56-64. PubMed ID: 22953501
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow trephine findings in acute myeloid leukaemia with multilineage dysplasia.
Ngo N; Lampert IA; Naresh KN
Br J Haematol; 2008 Feb; 140(3):279-86. PubMed ID: 17973948
[TBL] [Abstract][Full Text] [Related]
11. Loss of membrane expression of E-cadherin in leukemic erythroblasts.
Acs G; LiVolsi VA
Arch Pathol Lab Med; 2001 Feb; 125(2):198-201. PubMed ID: 11175634
[TBL] [Abstract][Full Text] [Related]
12. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase I is an early specific marker of normal human erythroid differentiation.
Villeval JL; Testa U; Vinci G; Tonthat H; Bettaieb A; Titeux M; Cramer P; Edelman L; Rochant H; Breton-Gorius J
Blood; 1985 Nov; 66(5):1162-70. PubMed ID: 3931725
[TBL] [Abstract][Full Text] [Related]
14. [Infant leukemia with t(1;22) presenting proliferation of erythroid and megakaryocytic cell lineages].
Oshima M; Fukushima T; Koike K; Hoshida C; Izumi I; Tsuchida M
Rinsho Ketsueki; 1999 Mar; 40(3):230-5. PubMed ID: 10222631
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical identification of erythroid precursors in paraffin embedded bone marrow sections: spectrin is a superior marker to glycophorin.
Sadahira Y; Kanzaki A; Wada H; Yawata Y
J Clin Pathol; 1999 Dec; 52(12):919-21. PubMed ID: 10711257
[TBL] [Abstract][Full Text] [Related]
16. Expression of blood group A antigen during erythroid differentiation in A1 and A2 subjects.
Tulliez M; Villeval JL; Lejeune F; Henri A; Testa U; Titeux M; Rochant H; Breton-Gorius J; Vainchenker W
Leukemia; 1987 Jan; 1(1):44-51. PubMed ID: 3669734
[TBL] [Abstract][Full Text] [Related]
17. α-Hemoglobin-stabilizing Protein: An Effective Marker for Erythroid Precursors in Bone Marrow Biopsy Specimens.
Yu H; Pinkus JL; Pinkus GS
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):51-6. PubMed ID: 25611244
[TBL] [Abstract][Full Text] [Related]
18. HBME-1 is expressed by erythroid precursors in early maturation stage and can be a valuable tool for evaluation of dyserythropoiesis in bone marrow core biopsy specimens.
Arana R; Lusina D; Braun T; Letestu R; Gardin C; Martin A
J Clin Pathol; 2016 Oct; 69(10):933-7. PubMed ID: 27484914
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of CD2-associated protein impaired the physiological functions of podocytes.
Zhang C; Jiang HJ; Chang Y; Fang Z; Sun XF; Liu JS; Deng AG; Zhu ZH
Cell Biol Int; 2009 Jun; 33(6):632-9. PubMed ID: 19306938
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry can be used to subtype acute myeloid leukemia in routinely processed bone marrow biopsy specimens. Comparison with flow cytometry.
Manaloor EJ; Neiman RS; Heilman DK; Albitar M; Casey T; Vattuone T; Kotylo P; Orazi A
Am J Clin Pathol; 2000 Jun; 113(6):814-22. PubMed ID: 10874882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
